Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Cambridge Cognition logo — Your all-in-one platform for cognitive data.

Cambridge Cognition

Your all-in-one platform for cognitive data.

Founded 2002 United Kingdom United Kingdom 68 employees Grant Total: $1.70M Biotechnology, Health Care

General Information

Company Name Cambridge Cognition
Founded Year 2002
Location United Kingdom United Kingdom
Employees 68
Industries Biotechnology, Health Care
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Cambridge Cognition. To contact Cambridge Cognition, visit cambridgecognition.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cambridge Cognition compare?

A PDF of Cambridge Cognition and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cambridge Cognition soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cambridge Cognition

Cambridge Cognition, founded in 2002 and headquartered in the United Kingdom, is a pioneering software technology company specializing in digital health solutions to tackle brain health challenges. The company operates at the intersection of Biotechnology and Health Care, developing cutting-edge products aimed at assessing cognitive health globally.

Renowned for its longevity and innovation in the field, its products, branded as the "your all-in-one platform for cognitive data," have been integral to the success of clinical trials for over 30 years. These digital solutions drive efficiency and precision for leading pharmaceutical and biotech firms, academic institutions, and health organizations worldwide.

Their most recent activity, a Grant investment on 29 May 2024, signals ongoing growth and potential for further expansion. Cambridge Cognition remains an appealing prospect for investors keen on revolutionizing cognitive health diagnostics and therapeutics with comprehensive digital tools.

Business keywords: Digital Health, Cognitive Assessments, Neuroscience, Clinical Trials, Pharmaceutical Efficiency, Biotech Solutions, Brain Health, Cognitive Health Software, Patient Stratification, Mental Health Technology, Alzheimer's Disease Detection, Dementia Research, Academic Collaboration, CANTAB

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Undisclosed -
29 May 2024
Post IPO Equity $1.00M -
23 Apr 2024
Grant $500.00K -
23 Apr 2024
Grant $200.00K 1
Alzheimer's Drug Discovery Foundation
21 Jan 2009

Latest News

View All
Monument Therapeutics secures £850K to advance schizophrenia treatment with MT1988 — Tech
Monument Therapeutics secures £850K to advance schizophrenia treatment with MT1988
Tech Feb 25, 2025

Cambridge Cognition Alternatives & Competitors

View All Alternatives
Cambridge Cognition vs
AccendoWave
AccendoWave United States

AccendoWave - A Pain Data Company

1 employees
Biotechnology, Health Care
Compare Cambridge Cognition vs AccendoWave
Cambridge Cognition vs
Quest Diagnostics
Quest Diagnostics United States

Working together to create a healthier world, one life at a time.

IPO
33096 employees
Biotechnology, Health Care
Compare Cambridge Cognition vs Quest Diagnostics
Cambridge Cognition vs
Quincy Bioscience
Quincy Bioscience United States

Biotechnology company focused on discovery and development novel of technologies.

Venture round
63 employees
Biotechnology, Health Care
Also compare with: Cambridge Cognition vs HealthMatch HealthMatch View all alternatives

FAQ About Cambridge Cognition

Your all-in-one platform for cognitive data.
Cambridge Cognition was founded in 2002.
Cambridge Cognition is headquartered in United Kingdom.
Cambridge Cognition operates in Biotechnology and Health Care. Its work centres on Digital Health, Cognitive Assessments, Neuroscience and Clinical Trials.
Cambridge Cognition has approximately 68 employees.
Cambridge Cognition has completed 4 funding rounds, raising a total of $1.70M. The latest funding stage is Grant.
Top alternatives and competitors to Cambridge Cognition include AccendoWave, Quest Diagnostics, Quincy Bioscience, HealthMatch , ieso. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cambridge Cognition and AccendoWave are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cambridge Cognition, https://bouncewatch.com/company/cambridge-cognition, updated 30 July 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout